Vaccine Safety & Efficacy

Vaccine efficacy refers to the ability of vaccines to bring about the intended beneficial effects on vaccinated individuals in a defined population under ideal conditions of use. The potential benefits of an effective vaccine – e.g. promotion of health and well-being, and protection from illness and its physical, psychological and socioeconomic consequences must be weighed against the potential risk of an adverse event following immunization (AEFI) with that vaccine. Vaccine-associated risk is the probability of an adverse or unwanted outcome occurring, and the severity of the resulting harm to the health of vaccinated individuals in a defined population following immunization with a vaccine under ideal conditions of use.

Related: Vaccines Conferences | World Vaccine Congress | Immunology Conferences | Vaccines Conferences 2019 | Immunization Conferences 2019 | HIV Vaccines Conferences | Vaccines Relative Conferences

  • Usage and awareness in public
  • Anaphylaxis
  • Vaccine safety and quality
  • Anaphylactic hypersensitivity
  • Safe immunization schedules
  • Quality control and assurance of vaccines
  • Safety and efficacy of attenuated vaccine
  • Biomarkers for vaccine safety and efficacy

Related Conference of Vaccine Safety & Efficacy

December 06-07, 2018

International Congress on Vaccines & Immunology

Amsterdam, Netherlands
March 18-19, 2019

33rdAnnual Vaccines & Vaccination Congress

New York, USA
March 18-19, 2019

35th World Vaccines & Immunization Congress

Novotel Brisbane, Australia
March 21-22, 2019

32nd International Conference on Vaccines and Immunization

Hotel Holiday Inn, Aurelia Rome, Italy
August 12-13, 2019

34th World Congress on Vaccines and Immunization

Auckland,Newzealand

Vaccine Safety & Efficacy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in